Oliver Chen, TD Cowen senior retail analyst, joins 'Money Movers' to discuss Wall Street's reaction to Walmart's quarterly ...

TD Cowen raised the firm’s price target on Analog Devices (ADI) to $280 from $260 and keeps a Buy rating on the shares. The firm said they ...

Charles Schwab (NYSE:SCHW – Get Free Report) was upgraded by equities researchers at TD Cowen from a “hold” rating to a “buy” ...

TD Cowen analyst Stacy Ku maintained a Buy rating on Supernus Pharmaceuticals (SUPN – Research Report) today and set a price target of $44.00.

TriNet Group (NYSE:TNET – Get Free Report) was downgraded by equities research analysts at TD Cowen from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday, Ratings ...

Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates ...

TD Cowen reiterated its Buy rating on Apollo Global Management (NYSE:APO) shares, maintaining a price target of $214.00.

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that members of the executive team are scheduled to participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference on Tuesday, ...

Skye is focused on unlocking new therapeutic pathways for metabolic health through the development of next-generation ...

Investors and the general public are invited to listen to a live webcast of the presentation through the "Investors" section ...